Name of bioresource/bank
GIE NeuroBioSource: Biobank
Name of Principal Investigator
Address of institution where award is held
|Hop La Salpetriere
|47, Blvd de l’Hopital
|75651 Cedex 13
Contact email (e.g. manager or coordinator)
Marie-Claire Artaud;[email protected]
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Parkinson’s disease Spinocerebellar ataxia (SCA)
Q2a What DNA collection does your resources hold?
Q2b What cell lines does your resource hold?
Q2c What tissue (including post-mortem tissue) does your resource hold?
Q3 Are human tissues/samples/DNA from
Post-mortem donors: brain Post-mortem donors: spinal cord
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In most samples
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Access independent of collaboration with PI Access Committee mechanism National access Access to industry Applicant needs to provide separate external ethics approval